Late stent thrombosis associated with late stent malapposition after drug-eluting stenting: A case report

Korean Circulation Journal

Volumn 36, Issue 6, 2006, Pages 472-475

  Choi, Bong Ryong ^a   Lee, Cheol Whan ^a   Park, Seong Wook ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Stent; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; PACLITAXEL;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG ELUTING STENT; HEART INFARCTION; HUMAN; INTRAVASCULAR ULTRASOUND; MALE; STENT; THROMBOSIS;

EID: 33746238192     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2006.36.6.472     Document Type: Article

References (14)

1. Cutlip DE, Baim DS, Ho KK, et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 2001;103:1967-71.
2. Orford JL, Lennon R, Melby S, et al. Frequency and correlates of coronary stent thrombosis in the modem era: analysis of a single center registry. J Am Coll Cardiol 2002;40:1567-72.
3. Park SH , Hong GR, Seo HS, Tank SJ. Stent thrombosis after successful drug-eluting stent implantation. Korean Circ J 2005;35:163-71.
4. Uren NG, Schwarzacher SP, Metz JA, et al. Predictors and outcomes of stent thrombosis: an intravascular ultrasound registry. Eur Heart J 2002;23:124-32.
5. Kastrati A, Koch W, Berger PB, et al. Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. J Am Coll Cardiol 2000;36:2168-73.
6. Wenawesser P, Dorffler-Melly J, Imboden K, et al. Stent thrombosis is associated with an impaired response to antiplatelet therapy. J Am Coll Cardiol 2005;45:1748-52.
7. Ong AT, McFaden EP, Reger E, de Jaegere PP, vanDombur PT, Serrys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. JAm Coll Cardiol 2005;45:2088-92.
8. Iakovou I, Schmidt T, Bonizzouni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30.
9. Fujii K, Curlier SG, Mintz GS, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 2005;45:995-8.
10. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drugeluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-21.
11. Hong MK, Mintz GS, Lee CW, et al. Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation. Circulation 2004;109:881-6.
12. Degertekin M, Serruys PW, Tanabe K, et al. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis. Circulation 2003;108:2747-50.
13. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxeleluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31.
14. Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004;109:701-5.